<DOC>
	<DOCNO>NCT02050932</DOCNO>
	<brief_summary>Background : Oral iron supplementation ( OIS ) widely-used strategy treat iron deficiency anemia . However , absorption OIS often low response variable . To overcome , large dos give may reduce compliance due gastric irritation . Thus , OIS dose low , maximize absorption . The prevail serum hepcidin concentration ( SHep ) major determinant iron absorption erythrocyte iron utilization . Based limited data human , SHep increase single OIS dose duration increase uncertain : In recent study conduct laboratory find last approx . 24 h. Also , data increase SHep determine absorption dose oral iron . Is threshold SHep subsequent iron absorption sharply reduce ? Better understanding relationship would valuable design effective safer OIS regimens . Objectives : 1 ) Determine whether two consecutive dosage 60 mg Fe differently affect hepcidin response iron bioavailability ( Study 1 ) 2 ) Compare bioavailability iron supplement dosage give different time day ( Study 2 ) . Methods/Subjects : Healthy female subject screen low iron status . Anemic subject exclude study . Thirty two subject include serum ferritin &lt; 20 Âµg/L , C-reactive protein &lt; 5 mg/L Hemoglobin &gt; 117 g/L . Subjects randomize two group Hepcidin ( sHep ) iron status marker monitor day 1 ( baseline ) . Subjects receive iron supplement dosages 60 mg stable iron isotopes 54Fe , 57Fe , 58Fe form 4 mg FeSO4 . Prior administration blood sample collect monitor sHep iron status marker . Outcome : The combine use stable iron isotope sensitive SHep assay allow good understand iron-hepcidin relationship may enable design effective OIS regimen .</brief_summary>
	<brief_title>The Optimization Iron Bioavailability Supplements Using Hepcidin Levels Humans</brief_title>
	<detailed_description />
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Hepcidins</mesh_term>
	<criteria>Generally healthy , blood donation last 4 month , pregnant , lactating , take vitamin mineral supplement 2 week prior study , non smoker , weight &lt; 65 Kg , BMI 18 25 . No anemia ( defined 11.7 g/dl , Serum ferritin level &lt; 20 microgram/L ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>hepcidin</keyword>
	<keyword>iron bioavailability</keyword>
	<keyword>iron supplementation</keyword>
</DOC>